Cho BC - Search Results

1

A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer.

Modjtahedi H, Cho BC, Michel MC, Solca F. Modjtahedi H, et al. Among authors: cho bc. Naunyn Schmiedebergs Arch Pharmacol. 2014 Jun;387(6):505-21. doi: 10.1007/s00210-014-0967-3. Epub 2014 Mar 19. Naunyn Schmiedebergs Arch Pharmacol. 2014. PMID: 24643470 Free PMC article. Review.

2

Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells.

Kim SM, Kim JS, Kim JH, Yun CO, Kim EM, Kim HK, Solca F, Choi SY, Cho BC. Kim SM, et al. Among authors: cho bc. Cancer Lett. 2010 Oct 28;296(2):150-9. doi: 10.1016/j.canlet.2010.04.006. Epub 2010 May 4. Cancer Lett. 2010. PMID: 20444542

3

Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation.

Kim SM, Kwon OJ, Hong YK, Kim JH, Solca F, Ha SJ, Soo RA, Christensen JG, Lee JH, Cho BC. Kim SM, et al. Among authors: cho bc. Mol Cancer Ther. 2012 Oct;11(10):2254-64. doi: 10.1158/1535-7163.MCT-12-0311. Epub 2012 Aug 13. Mol Cancer Ther. 2012. PMID: 22891040

4

Glycolysis inhibition sensitizes non-small cell lung cancer with T790M mutation to irreversible EGFR inhibitors via translational suppression of Mcl-1 by AMPK activation.

Kim SM, Yun MR, Hong YK, Solca F, Kim JH, Kim HJ, Cho BC. Kim SM, et al. Among authors: cho bc. Mol Cancer Ther. 2013 Oct;12(10):2145-56. doi: 10.1158/1535-7163.MCT-12-1188. Epub 2013 Jul 24. Mol Cancer Ther. 2013. PMID: 23883584

5

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.

Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, Dechaphunkul A, Imamura F, Nogami N, Kurata T, Okamoto I, Zhou C, Cho BC, Cheng Y, Cho EK, Voon PJ, Planchard D, Su WC, Gray JE, Lee SM, Hodge R, Marotti M, Rukazenkov Y, Ramalingam SS; FLAURA Investigators. Soria JC, et al. Among authors: cho ek, cho bc. N Engl J Med. 2018 Jan 11;378(2):113-125. doi: 10.1056/NEJMoa1713137. Epub 2017 Nov 18. N Engl J Med. 2018. PMID: 29151359 Free article. Clinical Trial.

6

Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC.

Lee EJ, Oh SY, Lee YW, Kim JY, Kim MJ, Kim TH, Lee JB, Hong MH, Lim SM, Baum A, Woelflingseder L, Engelhardt H, Petronczki M, Solca F, Yun MR, Cho BC. Lee EJ, et al. Among authors: cho bc. Clin Cancer Res. 2024 Apr 15;30(8):1582-1594. doi: 10.1158/1078-0432.CCR-23-2951. Clin Cancer Res. 2024. PMID: 38330145

7

Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cells.

Choi JM, Jang JY, Choi YR, Kim HR, Cho BC, Lee HW. Choi JM, et al. Among authors: cho bc. Lung Cancer. 2015 Nov;90(2):175-81. doi: 10.1016/j.lungcan.2015.08.019. Epub 2015 Sep 3. Lung Cancer. 2015. PMID: 26342551

8

ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer.

Marinis F, Wu YL, de Castro G Jr, Chang GC, Chen YM, Cho BC, Freitas HC, Jiang L, Kim SW, Martin C, Metro G, Provencio M, Vansteenkiste J, Vicente D, Zhou Q, Miranda MF, Bakker NA, Rigas JR, Cheema PK. Marinis F, et al. Among authors: cho bc. Future Oncol. 2019 Sep;15(26):3003-3014. doi: 10.2217/fon-2019-0324. Epub 2019 Jul 24. Future Oncol. 2019. PMID: 31339357

9

Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer.

Pyo KH, Lim SM, Kim HR, Sung YH, Yun MR, Kim SM, Kim H, Kang HN, Lee JM, Kim SG, Park CW, Chang H, Shim HS, Lee HW, Cho BC. Pyo KH, et al. Among authors: cho bc. J Thorac Oncol. 2017 Mar;12(3):491-500. doi: 10.1016/j.jtho.2016.10.022. Epub 2016 Nov 9. J Thorac Oncol. 2017. PMID: 27836576 Free article.

10

Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs.

Lee CK, Kim S, Lee JS, Lee JE, Kim SM, Yang IS, Kim HR, Lee JH, Kim S, Cho BC. Lee CK, et al. Among authors: cho bc. Lung Cancer. 2017 Nov;113:106-114. doi: 10.1016/j.lungcan.2017.09.005. Epub 2017 Sep 12. Lung Cancer. 2017. PMID: 29110836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

721 results

Search Page